EcoDrugPlus

Carbonic Anhydrase 7-Like

Ensembl ID : ENSOTSG00005041621
Gene Symbol: LOC112232238
3 Cross references
214 Possible Orthologues:

Carbonic Anhydrase 7-Like

Ensembl ID : ENSOTSG00005000699
Gene Symbol: LOC112249101
3 Cross references
214 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSOTSG00005033283
Gene Symbol: CA4A
1 Cross references
206 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSOTSG00005032080
Gene Symbol: CA4A
1 Cross references
207 Possible Orthologues:

Carbonic Anhydrase Iv B

Ensembl ID : ENSOTSG00005009307
Gene Symbol: CA4B
1 Cross references
190 Possible Orthologues:

Carbonic Anhydrase Va

Ensembl ID : ENSOTSG00005033420
Gene Symbol: CA5A
1 Cross references
225 Possible Orthologues:

Carbonic Anhydrase Xiv

Ensembl ID : ENSOTSG00005035456
Gene Symbol: CA14
1 Cross references
201 Possible Orthologues:

Carbonic Anhydrase Xiv

Ensembl ID : ENSOTSG00005014847
Gene Symbol: CA14
1 Cross references
201 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSOTSG00005033197
Gene Symbol: CSNK1E
1 Cross references
208 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSOTSG00005004389
Gene Symbol: CSNK1E
1 Cross references
208 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSOTSG00005045188
Gene Symbol: CSNK1E
1 Cross references
190 Possible Orthologues:

Casein Kinase I-Like

Ensembl ID : ENSOTSG00005024010
Gene Symbol: LOC112258765
3 Cross references
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).